Precision BioSciences

Precision BioSciences

Signal active

Organization

Contact Information

Overview

Precision BioSciences is a biotechnology company dedicated to improving lives through its next-generation gene editing technology, ARCUS.

Precision BioSciences’ mission is to translate the world’s most powerful genome editing technology into greatly needed products throughout the life sciences. Precision’s proprietary ARCUS genome editing technology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome.

About

Industries

Biotechnology, Health Care, Medical, Genetics

Founded

2006

Employees

101-250

Headquarters locations

United States, North America

Social

N/A

Profile Resume

Precision BioSciences headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Genetics sector. The company focuses on Biotechnology and has secured $25.5B in funding across 96 round(s). With a team of 101-250 employees, Precision BioSciences is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Precision BioSciences, raised $25.6M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Matthew Kane

Matthew Kane

Co-Founder & Chief Executive Officer

imagePlace Jeff Smith

Jeff Smith

Co-Founder, Chief Technical Officer and Chief Science Officer

imagePlace Michael Amoroso

Michael Amoroso

President & CEO

imagePlace Juli Blanche

Juli Blanche

Chief People Officer

imagePlace Naresh Tanna

Naresh Tanna

Vice President of Investor Relations

Funding Rounds

Funding rounds

6

Investors

9

Lead Investors

0

Total Funding Amount

$265.1M

Details

3

Precision BioSciences has raised a total of $265.1M in funding over 3 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2018Early Stage Venture110.0M
2006Seed
2015Early Stage Venture25.6M

Investors

Precision BioSciences is funded by 41 investors.

Investor NameLead InvestorFunding RoundPartners
The Longevity Fund-FUNDING ROUND - The Longevity Fund25.6M
Eight Roads Ventures-FUNDING ROUND - Eight Roads Ventures25.6M
Precision BioSciences-FUNDING ROUND - Precision BioSciences25.6M
Ziegler Link-Age Funds-FUNDING ROUND - Ziegler Link-Age Funds25.6M

Recent Activity

There is no recent news or activity for this profile.